Takeda Takes Aim At Proposed Generic Drug In New Delaware Patent Case
WILMINGTON, Del. — An application by Mylan Pharmaceuticals Inc. to market a generic version of the brand-name drug Colcrys would infringe 17 patents, according to a lawsuit filed Oct. 24 in...To view the full article, register now.
Already a subscriber? Click here to view full article